Literature DB >> 31287551

RE: Universal Tumor DNA BRCA1/2 Testing of Ovarian Cancer: Prescreening PARPi Treatment and Genetic Predisposition.

Federica Tomao, Pierluigi Benedetti Panici, Silverio Tomao.   

Abstract

Entities:  

Year:  2020        PMID: 31287551      PMCID: PMC7156938          DOI: 10.1093/jnci/djz138

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  5 in total

Review 1.  Current perspectives on recommendations for BRCA genetic testing in ovarian cancer patients.

Authors:  Ignace Vergote; Susana Banerjee; Anne-Marie Gerdes; Christi van Asperen; Christian Marth; Fatima Vaz; Isabelle Ray-Coquard; Dominique Stoppa-Lyonnet; Antonio Gonzalez-Martin; Jalid Sehouli; Nicoletta Colombo
Journal:  Eur J Cancer       Date:  2016-11-04       Impact factor: 9.162

Review 2.  Guidance Statement On BRCA1/2 Tumor Testing in Ovarian Cancer Patients.

Authors:  Ettore Capoluongo; Gillian Ellison; José Antonio López-Guerrero; Frederique Penault-Llorca; Marjolijn J L Ligtenberg; Susana Banerjee; Christian Singer; Eitan Friedman; Birgid Markiefka; Peter Schirmacher; Reinhard Büttner; Christi J van Asperen; Isabelle Ray-Coquard; Volker Endris; Suzanne Kamel-Reid; Natalie Percival; Jane Bryce; Benno Röthlisberger; Richie Soong; David Gonzalez de Castro
Journal:  Semin Oncol       Date:  2017-09-15       Impact factor: 4.929

3.  Integrated genomic analyses of ovarian carcinoma.

Authors: 
Journal:  Nature       Date:  2011-06-29       Impact factor: 49.962

4.  Novel BRCA1 and BRCA2 Tumor Test as Basis for Treatment Decisions and Referral for Genetic Counselling of Patients with Ovarian Carcinomas.

Authors:  Robbert D A Weren; Arjen R Mensenkamp; Michiel Simons; Astrid Eijkelenboom; Aisha S Sie; Hicham Ouchene; Monique van Asseldonk; Encarna B Gomez-Garcia; Marinus J Blok; Joanne A de Hullu; Marcel R Nelen; Alexander Hoischen; Johan Bulten; Bastiaan B J Tops; Nicoline Hoogerbrugge; Marjolijn J L Ligtenberg
Journal:  Hum Mutat       Date:  2016-11-09       Impact factor: 4.878

5.  Universal Tumor DNA BRCA1/2 Testing of Ovarian Cancer: Prescreening PARPi Treatment and Genetic Predisposition.

Authors:  Janet R Vos; Ingrid E Fakkert; Joanne A de Hullu; Anne M van Altena; Aisha S Sie; Hicham Ouchene; Riki W Willems; Iris D Nagtegaal; Marjolijn C J Jongmans; Arjen R Mensenkamp; Gwendolyn H Woldringh; Johan Bulten; Edward M Leter; C Marleen Kets; Michiel Simons; Marjolijn J L Ligtenberg; Nicoline Hoogerbrugge
Journal:  J Natl Cancer Inst       Date:  2020-02-01       Impact factor: 13.506

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.